🇺🇸 FDA
Pipeline program

Songling Xuemaikang Capsules

2023XL012-3

Approved small_molecule active

Quick answer

Songling Xuemaikang Capsules for Hypertension,Essential is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Hypertension,Essential
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials